Concepedia

Paola M. Homan‐Weert

PM

Statistics

Publications

2

Citations

50

H-Index

2

Active since

2023

Affiliations

Erasmus MC(Current)

Cancer Center Amsterdam

Vrije Universiteit Amsterdam

Amsterdam University Medical Centers

Paola M. Homan‐Weert is an author at Erasmus MC specializing in daratumumab therapy, antibody-dependent cell-mediated cytotoxicity, and natural killer cell regulation.

Publications per year

2023–2025

2

Publications

2

NK Cell Phenotype Is Associated With Response and Resistance to Daratumumab in Relapsed/Refractory Multiple Myeloma

Christie P.M. Verkleij, Kristine A. Frerichs, Marloes E.C. Broekmans et al. · HemaSphere · 2023 · 36 citations · Full text

, , +17

The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy

Charlotte L.B.M. Korst, Sabrin Tahri, Carolien Duetz et al. · Blood · 2025 · 14 citations · Full text

, , +17

1–2 of 2